Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,585,986 papers from all fields of science
Search
Sign In
Create Free Account
Power mobility device, not coded by dme pdac or does not meet criteria
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status
C. Liang
,
Jin Xu
,
+6 authors
Xianjun Yu
Autophagy
2020
Corpus ID: 182948746
ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal malignancies. Given that macroautophagy…
Expand
2020
2020
Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer
Ying Wu
,
Yuexiao Tang
,
+8 authors
Wei Chen
Theranostics
2020
Corpus ID: 209391607
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with poor prognosis. Insights into the roles of MicroRNAs…
Expand
2019
2019
Clinical significance and prospective molecular mechanism of C-C motif chemokine receptors in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
Xin Zhou
,
Xiwen Liao
,
+14 authors
T. Peng
Oncology Report
2019
Corpus ID: 201115338
The present study aimed to determine the clinical significance and potential molecular mechanisms of C-C motif chemokine receptor…
Expand
Highly Cited
2019
Highly Cited
2019
Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin.
Wei Chen
,
Yue Zhou
,
+9 authors
T. Liang
Biomaterials
2019
Corpus ID: 55702177
2015
2015
Abstract B18: MicroRNA-21 is involved in pancreatic cancer fibroblast tumor supportiveness
Andrew H. Nguyen
,
Luyi Li
,
Paul A. Toste
,
N. Wu
,
T. Donahue
2015
Corpus ID: 79447964
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by poor survival despite current medical and surgical…
Expand
2015
2015
Accuracy of pre-surgical evaluation in patients with suspected pancreatic malignancy
J. Carvalho
,
S. Fernandes
,
T. Antunes
,
J. Velosa
2015
Corpus ID: 76047777
2014
2014
Solid-pseudopapillary neoplasm (SPN) of the pancreas: An enigmatic entity
N. Vassos
,
A. Agaimy
,
P. Klein
,
W. Hohenberger
,
R. Croner
2014
Corpus ID: 72114632
2013
2013
Structural imaging of the pancreas in rat using micro-CT: application to a non-invasive longitudinal evaluation of pancreatic ductal carcinoma monitoring
C. Akladios
,
G. Bour
,
Z. Raykov
,
D. Mutter
,
J. Marescaux
,
M. Aprahamian
2013
Corpus ID: 87706085
The aim of the study was to evaluate the feasibility of a longitudinal non-invasive monitoring of rat pancreatic ductal…
Expand
2013
2013
Efemp1 and p27Kip1 modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models
Sandra Diersch
,
Wenzel Patrick
,
+11 authors
G. Schneider
OncoTarget
2013
Corpus ID: 15871921
Pancreatic ductal adenocarcinoma (PDAC) remains a dismal disease with a poor prognosis and targeted therapies have failed in the…
Expand
2012
2012
Abstract A2: Autoantibody signature in pancreatic ductal adenocarcinoma.
M. Capello
,
M. Milella
,
+8 authors
E. Petricoin
2012
Corpus ID: 72442214
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized by rapid progression, invasiveness and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required